Sign In

CPG Infobase: Clinical Practice Guidelines

0 comment(s)

Record Id:
13786
Title:
Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation
Fulltext:
View PDF
Publication/Review date:
2013-Mar 
Producers:
Canadian Agency for Drugs and Technologies in Health

Bibliographic Source

Place of Publication:
Ottawa (ON)
Publisher(s):
Canadian Agency for Drugs and Technologies in Health
Date Accessed:
2013-05-14
Pages/Size:
19  Page(s)
References:
49

Subject Information

Specialties:
Cardiology,
Conditions:
Atrial Fibrillation ; Stroke ;
Domains:
Preventive
Target Populations:
General
Target Gender:
Unknown
MeSH:
Warfarin; Atrial Fibrillation; Stroke; Risk Assessment; Platelet Aggregation Inhibitors; Aspirin; Anticoagulants;

Copyright:

The copyright of this guideline and its companion documents belongs to: Canadian Agency for Drugs and Technologies in Health

Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

Discuss this CPG

Share your ideas and expertise on this topic.

​​​